Post-trial access to treatment: corporate best practices

SOMO Centre for Research on Multinational Corporations (2015)
Download Edit this record How to cite View on PhilPapers
The paper Post-Trial Acces To Treatment (PTA) offers an insight into current corporate policies and corporate best practices relating to the provision of PTA in low and middle income countries based on company sources. In these countries there is a greater appeal for pharmaceutical companies to take responsibility for providing PTA. However, the practice of providing PTA is the exception rather than the rule.
PhilPapers/Archive ID
Upload history
Archival date: 2015-03-03
View other versions
Added to PP index

Total views
159 ( #36,021 of 64,047 )

Recent downloads (6 months)
7 ( #54,266 of 64,047 )

How can I increase my downloads?

Downloads since first upload
This graph includes both downloads from PhilArchive and clicks on external links on PhilPapers.